Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable

D A Halon1, A Merdler, A Shefer

  • 1Department of Cardiology, Lady Davis Carmel Hospital, Haifa, Israel.

Insights

Late restenosis after percutaneous transluminal coronary angioplasty (PTCA) for unstable angina is predicted by multiple irregularities and decreased coronary flow. Patients with these factors require careful follow-up to manage potential restenosis.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Unstable angina pectoris (UAP) poses significant risks.
  • Percutaneous transluminal coronary angioplasty (PTCA) is a common revascularization strategy for UAP.
  • Understanding determinants of late restenosis after PTCA is crucial for patient management.

Purpose of the Study:

  • To identify predictors of late restenosis after PTCA in patients with UAP.
  • To assess the feasibility and outcomes of early revascularization by PTCA in UAP.

Main Methods:

  • Prospective study of 90 patients with UAP undergoing PTCA.
  • Angiographic follow-up at 9 ± 7 months to assess restenosis.
  • Logistic regression analysis to identify independent predictors of restenosis.

Main Results:

  • Successful PTCA achieved in 93% of patients with low complication rates.
  • Late restenosis observed in 25% of lesions studied.
  • Independent predictors of restenosis included multiple irregularities and decreased coronary perfusion (Thrombolysis in Myocardial Infarction grade < 3).

Conclusions:

  • Early revascularization by PTCA is feasible in UAP patients.
  • Patients with multiple irregular lesions, decreased coronary perfusion, or intraluminal thrombus at PTCA are at higher risk for late restenosis.
  • Close follow-up is recommended for these high-risk patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
696
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
477
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
483
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
552